TAPINAROF

TAPINAROF was reported 1974 times

TAPINAROF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE FOLLICULITIS 45 0.6250
1 ONYCHOPAPILLOMA 1 0.5000
2 SYSTEMIC CONTACT DERMATITIS 2 0.2857
3 APPLICATION SITE JOINT SWELLING 1 0.2000
4 INFUSION SITE ECZEMA 1 0.1000
5 FOLLICULITIS GENITAL 1 0.0769
6 APPLICATION SITE CYST 1 0.0769
7 APPLICATION SITE CELLULITIS 4 0.0597
8 ECZEMATOUS CHEILITIS 1 0.0588
9 FOLLICULAR DISORDER 2 0.0556
10 MILIA 17 0.0468
11 MEDICAL DEVICE SITE BURN 1 0.0455
12 SCROTAL CYST 3 0.0353
13 INFUSION SITE DERMATITIS 1 0.0345
14 PAROTIDECTOMY 1 0.0286
15 FOLLICULITIS 292 0.0278
16 APPLICATION SITE ACNE 8 0.0163
17 KERATOSIS PILARIS 4 0.0160
18 SCLEREMA 1 0.0123
19 DERMATITIS CONTACT 134 0.0117
20 RENAL CELL CARCINOMA STAGE I 1 0.0115
21 APPLICATION SITE PAPULES 12 0.0113
22 APPLICATION SITE PUSTULES 4 0.0110
23 KERATOACANTHOMA 7 0.0102
24 APPLICATION SITE OEDEMA 3 0.0093
25 ALLERGIC RESPIRATORY DISEASE 1 0.0072
26 CYTOLOGY ABNORMAL 1 0.0067
27 RASH FOLLICULAR 1 0.0065
28 NAIL BED INFLAMMATION 2 0.0063
29 APPLICATION SITE INFLAMMATION 8 0.0058
30 ALOPECIA SCARRING 1 0.0055
31 HERPES ZOSTER MENINGITIS 1 0.0055
32 GENITAL TRACT INFLAMMATION 1 0.0050
33 GUTTATE PSORIASIS 4 0.0049
34 LICHENIFICATION 2 0.0049
35 CAROTID ENDARTERECTOMY 1 0.0048
36 INGROWN HAIR 3 0.0043
37 SWEAT GLAND TUMOUR 1 0.0043
38 THUNDERCLAP HEADACHE 1 0.0038
39 APPLICATION SITE DISCOLOURATION 15 0.0037
40 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
41 APPLICATION SITE DRYNESS 12 0.0035
42 BIOPSY KIDNEY 1 0.0035
43 EAR INFLAMMATION 1 0.0035
44 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
45 ERYTHEMA ANNULARE 1 0.0034
46 APPLICATION SITE SWELLING 17 0.0034
47 TRANSIENT ACANTHOLYTIC DERMATOSIS 1 0.0034
48 FEMALE ORGASMIC DISORDER 1 0.0030
49 PUSTULE 7 0.0030
50 COLOSTOMY CLOSURE 1 0.0029
51 PSEUDOSTROKE 1 0.0029
52 APPLICATION SITE ULCER 2 0.0028
53 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
54 APPLICATION SITE PRURITUS 62 0.0027
55 APPLICATION SITE PAIN 60 0.0027
56 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
57 PENILE ERYTHEMA 1 0.0027
58 VIRAL PHARYNGITIS 1 0.0025
59 APPLICATION SITE HYPERSENSITIVITY 3 0.0025
60 APPLICATION SITE LACERATION 1 0.0024
61 APPLICATION SITE ERYTHEMA 63 0.0024
62 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
63 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
64 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
65 MECHANICAL URTICARIA 1 0.0021
66 MASTOCYTOSIS 1 0.0021
67 ECZEMA NUMMULAR 1 0.0020
68 APPLICATION SITE EXFOLIATION 8 0.0019
69 CYST REMOVAL 1 0.0019
70 NAIL RIDGING 1 0.0019
71 EAR SWELLING 4 0.0019
72 CORYNEBACTERIUM INFECTION 1 0.0019
73 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
74 SKIN DISCOMFORT 5 0.0019
75 INTERTRIGO 1 0.0018
76 PRODUCT CLOSURE ISSUE 1 0.0018
77 NAIL DYSTROPHY 1 0.0018
78 COLLAGEN DISORDER 1 0.0017
79 SKIN HYPOPIGMENTATION 3 0.0017
80 PAIN OF SKIN 45 0.0017
81 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
82 PENILE SWELLING 2 0.0016
83 DERMAL CYST 4 0.0016
84 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
85 PERIORAL DERMATITIS 1 0.0016
86 ALLERGIC OEDEMA 1 0.0015
87 CELLULITIS STAPHYLOCOCCAL 1 0.0015
88 ACROCHORDON 2 0.0015
89 INJECTION SITE EXFOLIATION 1 0.0015
90 APPLICATION SITE RASH 20 0.0015
91 SKIN HYPERTROPHY 4 0.0014
92 CERVICAL RADICULOPATHY 1 0.0014
93 PRODUCT DESIGN ISSUE 1 0.0014
94 APPLICATION SITE VESICLES 9 0.0014
95 SEBORRHOEIC KERATOSIS 2 0.0014
96 DIAPHRAGMATIC DISORDER 1 0.0013
97 EYELID EXFOLIATION 1 0.0013
98 PENILE HAEMORRHAGE 1 0.0012
99 SKIN BURNING SENSATION 87 0.0012
100 APPLICATION SITE IRRITATION 15 0.0012
101 SKIN HYPERPIGMENTATION 10 0.0012
102 ABSCESS DRAINAGE 1 0.0012
103 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
104 FOLLICULAR LYMPHOMA 1 0.0011
105 SWELLING OF EYELID 7 0.0011
106 APPLICATION SITE DERMATITIS 1 0.0011
107 DERMATITIS 22 0.0010
108 SKIN TEXTURE ABNORMAL 1 0.0010
109 PAPULE 7 0.0010
110 BENIGN BREAST NEOPLASM 1 0.0010
111 BREAST ABSCESS 1 0.0010
112 PIGMENTATION DISORDER 6 0.0010
113 BREAST NEOPLASM 1 0.0010
114 SKIN EROSION 3 0.0009
115 SKIN SWELLING 8 0.0009
116 PRODUCT SELECTION ERROR 1 0.0009
117 APPLICATION SITE URTICARIA 2 0.0009
118 PRURITUS GENITAL 2 0.0008
119 GROIN ABSCESS 1 0.0008
120 COLON OPERATION 1 0.0008
121 BRONCHIAL HYPERREACTIVITY 1 0.0008
122 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
123 EYELID IRRITATION 2 0.0008
124 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
125 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
126 DERMATOMYOSITIS 2 0.0008
127 CHEMICAL BURN OF SKIN 2 0.0008
128 BILIARY OBSTRUCTION 1 0.0008
129 PHARYNGEAL ULCERATION 1 0.0008
130 PLASMA CELL MYELOMA REFRACTORY 1 0.0007
131 SKIN FISSURES 14 0.0007
132 RESPIRATORY SYMPTOM 2 0.0007
133 SCAB 8 0.0007
134 GENITAL RASH 1 0.0007
135 NOROVIRUS INFECTION 1 0.0007
136 SKIN WARM 4 0.0007
137 GENITAL PAIN 1 0.0007
138 SKIN DISCOLOURATION 30 0.0007
139 EYE ALLERGY 1 0.0006
140 DERMATITIS ATOPIC 34 0.0006
141 NEOPLASM SKIN 1 0.0006
142 SKIN EXFOLIATION 54 0.0006
143 BACTERIAL VAGINOSIS 1 0.0006
144 SKIN TIGHTNESS 3 0.0006
145 SQUAMOUS CELL CARCINOMA 6 0.0006
146 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
147 RASH VESICULAR 3 0.0006
148 PRURITUS 238 0.0006
149 DENTAL IMPLANTATION 1 0.0006
150 APPLICATION SITE BURN 3 0.0006
151 RASH ERYTHEMATOUS 29 0.0006
152 ERYTHEMA 124 0.0006
153 SKIN MASS 4 0.0006
154 TONSILLAR HYPERTROPHY 1 0.0006
155 PSORIASIS 77 0.0006
156 SKIN IRRITATION 27 0.0006
157 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
158 MILIARIA 1 0.0006
159 ACUTE SINUSITIS 1 0.0006
160 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
161 OTORRHOEA 1 0.0006
162 SWELLING FACE 37 0.0006
163 SKIN REACTION 8 0.0006
164 FOOD POISONING 3 0.0006
165 APPLICATION SITE DISCOMFORT 1 0.0006
166 ECZEMA 29 0.0006
167 ACNE 42 0.0006
168 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
169 HYPERTRICHOSIS 1 0.0005
170 ERYTHEMA MULTIFORME 5 0.0005
171 REBOUND EFFECT 6 0.0005
172 RETINAL OEDEMA 1 0.0005
173 GASTRIC INFECTION 2 0.0005
174 VOCAL CORD DISORDER 1 0.0005
175 REBOUND ATOPIC DERMATITIS 1 0.0005
176 SUDDEN HEARING LOSS 1 0.0005
177 EYELID PAIN 1 0.0005
178 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
179 SCRATCH 5 0.0005
180 EYE CONTUSION 1 0.0005
181 INFUSION SITE BRUISING 1 0.0005
182 PRODUCT PRESCRIBING ISSUE 10 0.0005
183 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
184 MIDDLE EAR EFFUSION 1 0.0005
185 LICHENOID KERATOSIS 1 0.0004
186 NECK SURGERY 1 0.0004
187 ROSACEA 2 0.0004
188 SKIN ABRASION 2 0.0004
189 DRY SKIN 56 0.0004
190 URINE FLOW DECREASED 1 0.0004
191 LYMPHADENITIS 1 0.0004
192 HAEMATOLOGICAL INFECTION 1 0.0004
193 SENSITIVE SKIN 3 0.0004
194 DENTAL OPERATION 1 0.0004
195 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
196 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
197 PEMPHIGOID 3 0.0004
198 INFLUENZA LIKE ILLNESS 32 0.0004
199 MENOPAUSE 1 0.0004
200 ACTINIC KERATOSIS 1 0.0004
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
202 WEIGHT BEARING DIFFICULTY 1 0.0004
203 SKIN WRINKLING 1 0.0004
204 RHINALGIA 1 0.0004
205 MACULE 1 0.0004
206 BLISTER 20 0.0004
207 RASH 152 0.0003
208 EYELID MARGIN CRUSTING 1 0.0003
209 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
210 STRABISMUS 1 0.0003
211 SKIN HAEMORRHAGE 5 0.0003
212 FACIAL PAIN 3 0.0003
213 DERMATITIS ACNEIFORM 2 0.0003
214 POLYMYALGIA RHEUMATICA 1 0.0003
215 RASH PRURITIC 17 0.0003
216 ABSCESS 5 0.0003
217 AUTOIMMUNE DISORDER 3 0.0003
218 PHARYNGEAL SWELLING 3 0.0003
219 LYMPHOCYTE COUNT INCREASED 1 0.0003
220 INFUSION SITE HAEMORRHAGE 1 0.0003
221 SUSPECTED COVID-19 1 0.0003
222 SKIN INJURY 1 0.0003
223 HEADACHE 182 0.0003
224 APPLICATION SITE REACTION 2 0.0003
225 HANGOVER 1 0.0003
226 DRUG ERUPTION 5 0.0003
227 FEAR OF INJECTION 2 0.0003
228 PHARYNGITIS STREPTOCOCCAL 3 0.0003
229 SEBORRHOEA 1 0.0003
230 CARDIAC DYSFUNCTION 1 0.0003
231 SUNBURN 2 0.0003
232 RASH PAPULAR 6 0.0003
233 FOOD ALLERGY 2 0.0003
234 RASH MACULAR 9 0.0003
235 ORAL INFECTION 1 0.0003
236 WOUND SECRETION 1 0.0003
237 FURUNCLE 2 0.0003
238 OESOPHAGEAL CANDIDIASIS 1 0.0003
239 URTICARIA 42 0.0003
240 SKIN PAPILLOMA 1 0.0002
241 BLEPHARITIS 1 0.0002
242 FUNGAL SKIN INFECTION 1 0.0002
243 BURSITIS 3 0.0002
244 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
245 SWELLING 23 0.0002
246 HYPERAESTHESIA 2 0.0002
247 SPINAL STENOSIS 1 0.0002
248 CYST 3 0.0002
249 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
250 SLEEP TERROR 1 0.0002
251 SKIN PLAQUE 2 0.0002
252 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
253 ABSCESS LIMB 1 0.0002
254 CHAPPED LIPS 1 0.0002
255 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
256 PARONYCHIA 1 0.0002
257 ABDOMINAL ABSCESS 1 0.0002
258 HYPERSENSITIVITY 42 0.0002
259 MALIGNANT MELANOMA 3 0.0002
260 THERAPY NON-RESPONDER 10 0.0002
261 SINUS CONGESTION 3 0.0002
262 OROPHARYNGEAL DISCOMFORT 2 0.0002
263 MIGRAINE 21 0.0002
264 INJECTION SITE PAPULE 1 0.0002
265 IMMUNE THROMBOCYTOPENIA 1 0.0002
266 TREATMENT FAILURE 18 0.0002
267 EYE OPERATION 1 0.0002
268 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
269 CONJUNCTIVITIS 4 0.0002
270 ARTHRITIS INFECTIVE 1 0.0002
271 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
272 LIP SWELLING 7 0.0002
273 PARAESTHESIA ORAL 3 0.0002
274 EAR PAIN 4 0.0002
275 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
276 VITREOUS FLOATERS 2 0.0002
277 ERYSIPELAS 1 0.0002
278 CELLULITIS 10 0.0002
279 INSURANCE ISSUE 3 0.0002
280 INITIAL INSOMNIA 2 0.0002
281 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
282 SKIN NECROSIS 1 0.0002
283 PERIORBITAL OEDEMA 1 0.0002
284 THERAPY PARTIAL RESPONDER 3 0.0002
285 TENDERNESS 2 0.0002
286 SERUM FERRITIN INCREASED 1 0.0002
287 EYE SWELLING 7 0.0002
288 COMPRESSION FRACTURE 1 0.0002
289 ANAL FISSURE 1 0.0002
290 INJECTION SITE DISCHARGE 1 0.0002
291 HIP SURGERY 1 0.0002
292 SKIN LACERATION 2 0.0002
293 SKIN LESION 5 0.0002
294 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
295 INJECTION SITE INJURY 1 0.0002
296 PERIORBITAL SWELLING 1 0.0002
297 EYELID OEDEMA 2 0.0002
298 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
299 SYMPTOM RECURRENCE 1 0.0002
300 SPINAL OPERATION 2 0.0002
301 NASAL DRYNESS 1 0.0002
302 INFUSION SITE SWELLING 1 0.0002
303 BLEPHAROSPASM 1 0.0002
304 SCREAMING 1 0.0002
305 ROTATOR CUFF SYNDROME 2 0.0002
306 INFLAMMATION 8 0.0002
307 HERPES SIMPLEX 1 0.0002
308 NODULE 2 0.0002
309 POLYP 1 0.0002
310 SKIN DISORDER 5 0.0001
311 OCULAR HYPERAEMIA 7 0.0001
312 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
313 ECCHYMOSIS 1 0.0001
314 APHONIA 2 0.0001
315 BURNING SENSATION 10 0.0001
316 LYMPHADENOPATHY 5 0.0001
317 THERAPY INTERRUPTED 10 0.0001
318 RHINORRHOEA 9 0.0001
319 RASH PUSTULAR 1 0.0001
320 GASTROENTERITIS 2 0.0001
321 NASAL CONGESTION 8 0.0001
322 ARTHROPOD BITE 1 0.0001
323 IMMUNODEFICIENCY 2 0.0001
324 THERAPEUTIC RESPONSE DECREASED 8 0.0001
325 PRODUCT AVAILABILITY ISSUE 3 0.0001
326 DISCOMFORT 8 0.0001
327 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
328 TENDONITIS 2 0.0001
329 APHTHOUS ULCER 1 0.0001
330 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
331 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
332 SLEEP DISORDER 9 0.0001
333 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
334 PRODUCT PRESCRIBING ERROR 3 0.0001
335 BLOOD DISORDER 1 0.0001
336 PSORIATIC ARTHROPATHY 5 0.0001
337 POLYURIA 1 0.0001
338 HERPES ZOSTER 7 0.0001
339 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
340 PHOTOSENSITIVITY REACTION 2 0.0001
341 DRY EYE 6 0.0001
342 INFUSION SITE ERYTHEMA 1 0.0001
343 CANDIDA INFECTION 2 0.0001
344 SCAR 2 0.0001
345 MUSCLE STRAIN 1 0.0001
346 JOINT STIFFNESS 3 0.0001
347 NAIL DISORDER 1 0.0001
348 FEELING HOT 7 0.0001
349 COLD SWEAT 2 0.0001
350 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
351 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
352 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
353 OPTIC NEURITIS 1 0.0001
354 HIDRADENITIS 1 0.0001
355 PNEUMONIA BACTERIAL 1 0.0001
356 PARAESTHESIA 17 0.0001
357 PRODUCT DISTRIBUTION ISSUE 1 0.0001
358 MIDDLE INSOMNIA 2 0.0001
359 DIARRHOEA HAEMORRHAGIC 1 0.0001
360 SPINAL DISORDER 1 0.0001
361 EYE INFLAMMATION 1 0.0001
362 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
363 SINUS BRADYCARDIA 1 0.0001
364 DYSPHONIA 6 0.0001
365 ORAL HERPES 2 0.0001
366 CHILLS 12 0.0001
367 HEPATOMEGALY 1 0.0001
368 THERAPY CHANGE 1 0.0001
369 KNEE OPERATION 1 0.0001
370 LIGAMENT SPRAIN 1 0.0001
371 HYPOTONIA 1 0.0001
372 DRUG INEFFECTIVE 130 0.0001
373 EAR DISCOMFORT 1 0.0001
374 THERAPY CESSATION 5 0.0001
375 PRODUCT PREPARATION ERROR 2 0.0001
376 HELICOBACTER INFECTION 1 0.0001
377 SWOLLEN TONGUE 3 0.0001
378 WEIGHT FLUCTUATION 1 0.0001
379 INJECTION SITE DISCOMFORT 1 0.0001
380 SKIN CANCER 2 0.0001
381 ASPIRATION 1 0.0001
382 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
383 STAPHYLOCOCCAL INFECTION 3 0.0001
384 INJECTION SITE NODULE 1 0.0001
385 FOOT DEFORMITY 1 0.0001
386 VIRAL INFECTION 3 0.0001
387 FUNGAL INFECTION 3 0.0001
388 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
389 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
390 MYALGIA 15 0.0001
391 NEPHROLITHIASIS 4 0.0001
392 VOMITING 41 0.0001
393 EYE IRRITATION 5 0.0001
394 COVID-19 15 0.0001
395 PRODUCT DOSE OMISSION ISSUE 25 0.0001
396 INJECTION SITE PAIN 26 0.0001
397 WRIST FRACTURE 1 0.0001
398 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
399 INJECTION SITE URTICARIA 2 0.0001
400 CARDIOMEGALY 1 0.0001
401 SMALL INTESTINAL OBSTRUCTION 1 0.0001
402 GENERALISED OEDEMA 1 0.0001
403 INJECTION SITE DISCOLOURATION 1 0.0001
404 PEMPHIGUS 1 0.0001
405 SECRETION DISCHARGE 1 0.0001
406 MUSCLE ATROPHY 1 0.0001
407 INJECTION SITE IRRITATION 1 0.0001
408 PERIPHERAL SWELLING 12 0.0001
409 SKIN ULCER 2 0.0001
410 EXPOSURE VIA SKIN CONTACT 2 0.0001
411 RESPIRATORY TRACT INFECTION 2 0.0001
412 BEDRIDDEN 1 0.0001
413 ORAL CANDIDIASIS 1 0.0001
414 IMMUNE SYSTEM DISORDER 1 0.0001
415 ANKYLOSING SPONDYLITIS 1 0.0001
416 ADVERSE REACTION 1 0.0001
417 THROAT TIGHTNESS 2 0.0001
418 MOOD ALTERED 2 0.0001
419 DEVICE MECHANICAL ISSUE 1 0.0001
420 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
421 ABNORMAL DREAMS 2 0.0001
422 OFF LABEL USE 63 0.0001
423 ABDOMINAL DISCOMFORT 12 0.0001
424 CARPAL TUNNEL SYNDROME 1 0.0001
425 PAIN IN JAW 2 0.0001
426 NEEDLE ISSUE 2 0.0001
427 BONE PAIN 4 0.0001
428 PAIN IN EXTREMITY 20 0.0001
429 COLON CANCER 1 0.0001
430 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
431 HYPOAESTHESIA ORAL 1 0.0001
432 HIP ARTHROPLASTY 1 0.0001
433 INJECTION SITE RASH 2 0.0001
434 NASOPHARYNGITIS 12 0.0001
435 ARTHRALGIA 27 0.0001
436 LYMPHOMA 1 0.0001
437 BASAL CELL CARCINOMA 1 0.0001
438 INSOMNIA 17 0.0001
439 BRAIN FOG 1 0.0001
440 PAIN 39 0.0001
441 DISEASE RECURRENCE 3 0.0001
442 ULCER 1 0.0001
443 INFLUENZA 7 0.0001
444 BACK DISORDER 1 0.0001
445 EYE DISORDER 2 0.0001
446 GAIT INABILITY 2 0.0001
447 EYE PRURITUS 2 0.0001
448 FACE OEDEMA 1 0.0001
449 CONDITION AGGRAVATED 18 0.0001
450 HEPATIC ENZYME INCREASED 4 0.0001
451 SINUSITIS 6 0.0001
452 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
453 HEART RATE DECREASED 2 0.0001
454 THIRST 1 0.0001
455 RESTLESS LEGS SYNDROME 1 0.0001
456 PANIC ATTACK 2 0.0001
457 RESTLESSNESS 2 0.0001
458 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
459 ANAPHYLACTIC REACTION 3 0.0001
460 BLOOD GLUCOSE ABNORMAL 1 0.0001
461 HEPATIC STEATOSIS 1 0.0001
462 NECK PAIN 3 0.0001
463 PRODUCT USE ISSUE 10 0.0001
464 EYE PAIN 3 0.0001
465 PHOTOPHOBIA 1 0.0001
466 FOOT FRACTURE 1 0.0001
467 SLEEP APNOEA SYNDROME 1 0.0001
468 INJECTION SITE SWELLING 4 0.0001
469 LOWER LIMB FRACTURE 1 0.0001
470 ACUTE RESPIRATORY FAILURE 1 0.0001
471 PALPITATIONS 6 0.0001
472 SURGERY 3 0.0001
473 KIDNEY INFECTION 1 0.0001
474 UPPER LIMB FRACTURE 1 0.0001
475 PREGNANCY 1 0.0000
476 EXTRA DOSE ADMINISTERED 2 0.0000
477 FEEDING DISORDER 1 0.0000
478 TASTE DISORDER 1 0.0000
479 NAUSEA 39 0.0000
480 FLUSHING 5 0.0000
481 INJECTION SITE WARMTH 1 0.0000
482 RIB FRACTURE 1 0.0000
483 KNEE ARTHROPLASTY 1 0.0000
484 OSTEOARTHRITIS 2 0.0000
485 RETCHING 1 0.0000
486 IMPAIRED WORK ABILITY 1 0.0000
487 PRODUCT DISPENSING ERROR 1 0.0000
488 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
489 ANGIOEDEMA 2 0.0000
490 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
491 LIVER DISORDER 2 0.0000
492 GLOSSODYNIA 1 0.0000
493 ORAL PAIN 1 0.0000
494 SNEEZING 1 0.0000
495 THROAT IRRITATION 2 0.0000
496 PYREXIA 15 0.0000
497 OROPHARYNGEAL PAIN 4 0.0000
498 BLOOD CHOLESTEROL INCREASED 2 0.0000
499 PRODUCTIVE COUGH 2 0.0000
500 CONTUSION 4 0.0000
501 FIBROMYALGIA 1 0.0000
502 PRESYNCOPE 1 0.0000
503 CEREBRAL INFARCTION 1 0.0000
504 BRONCHITIS 3 0.0000
505 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
506 DEPRESSION 9 0.0000
507 CARDIOVASCULAR DISORDER 1 0.0000
508 COUGH 11 0.0000
509 ILLNESS 4 0.0000
510 ANAPHYLACTIC SHOCK 1 0.0000
511 NERVOUSNESS 2 0.0000
512 PANCREATITIS 2 0.0000
513 DEPRESSED MOOD 2 0.0000
514 INJECTION SITE BRUISING 3 0.0000
515 EAR INFECTION 1 0.0000
516 DEHYDRATION 5 0.0000
517 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
518 DIARRHOEA 24 0.0000
519 FEAR 1 0.0000
520 OEDEMA 2 0.0000
521 PALLOR 1 0.0000
522 WOUND 1 0.0000
523 ASTHMA 4 0.0000
524 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
525 INTENTIONAL DOSE OMISSION 1 0.0000
526 INFECTION 5 0.0000
527 DECREASED APPETITE 8 0.0000
528 INTENTIONAL PRODUCT MISUSE 3 0.0000
529 DYSSTASIA 1 0.0000
530 GASTROINTESTINAL DISORDER 3 0.0000
531 RESPIRATORY DISORDER 1 0.0000
532 APHASIA 1 0.0000
533 LACRIMATION INCREASED 1 0.0000
534 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
535 VERTIGO 2 0.0000
536 EPILEPSY 1 0.0000
537 MUSCLE SPASMS 6 0.0000
538 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
539 HOSPITALISATION 5 0.0000
540 GYNAECOMASTIA 1 0.0000
541 MOVEMENT DISORDER 1 0.0000
542 HYPERHIDROSIS 4 0.0000
543 NIGHT SWEATS 1 0.0000
544 ATRIAL FIBRILLATION 3 0.0000
545 DYSPNOEA 17 0.0000
546 URINARY RETENTION 1 0.0000
547 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
548 CEREBROVASCULAR ACCIDENT 5 0.0000
549 CHEST DISCOMFORT 3 0.0000
550 INJECTION SITE REACTION 2 0.0000
551 NIGHTMARE 1 0.0000
552 HYPERKALAEMIA 1 0.0000
553 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
554 CEREBRAL HAEMORRHAGE 1 0.0000
555 CRYING 1 0.0000
556 DYSGEUSIA 2 0.0000
557 HYPOAESTHESIA 4 0.0000
558 MUSCULAR WEAKNESS 3 0.0000
559 BLOOD PRESSURE INCREASED 4 0.0000
560 GAIT DISTURBANCE 5 0.0000
561 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
562 DRUG DOSE OMISSION BY DEVICE 2 0.0000
563 ARTHRITIS 2 0.0000
564 ABNORMAL BEHAVIOUR 1 0.0000
565 PROSTATE CANCER 2 0.0000
566 PNEUMONIA 8 0.0000
567 NEUTROPHIL COUNT DECREASED 1 0.0000
568 ABDOMINAL PAIN UPPER 5 0.0000
569 INJECTION SITE ERYTHEMA 3 0.0000
570 POLLAKIURIA 1 0.0000
571 URINARY TRACT INFECTION 4 0.0000
572 HYPOACUSIS 1 0.0000
573 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
574 TACHYCARDIA 2 0.0000
575 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
576 PRODUCT QUALITY ISSUE 3 0.0000
577 DIZZINESS 11 0.0000
578 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
579 VISION BLURRED 3 0.0000
580 SUICIDAL IDEATION 2 0.0000
581 TINNITUS 1 0.0000
582 HYPOKALAEMIA 1 0.0000
583 BACK PAIN 5 0.0000
584 DYSPEPSIA 2 0.0000
585 SYNCOPE 2 0.0000
586 ACUTE KIDNEY INJURY 3 0.0000
587 FATIGUE 15 0.0000
588 BRADYCARDIA 1 0.0000
589 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
590 TREMOR 3 0.0000
591 ARTHROPATHY 1 0.0000
592 MEDICATION ERROR 1 0.0000
593 WEIGHT INCREASED 4 0.0000
594 OXYGEN SATURATION DECREASED 1 0.0000
595 HYPONATRAEMIA 1 0.0000
596 FLATULENCE 1 0.0000
597 LETHARGY 1 0.0000
598 MYOCARDIAL INFARCTION 3 0.0000
599 ABDOMINAL PAIN 4 0.0000
600 WHEEZING 1 0.0000
601 FEELING ABNORMAL 4 0.0000
602 JOINT SWELLING 2 0.0000
603 NO ADVERSE EVENT 3 0.0000
604 OEDEMA PERIPHERAL 2 0.0000
605 CHEST PAIN 3 0.0000
606 VISUAL IMPAIRMENT 2 0.0000
607 EXPOSURE DURING PREGNANCY 1 0.0000
608 AMNESIA 1 0.0000
609 INFUSION RELATED REACTION 1 0.0000
610 NEOPLASM MALIGNANT 1 0.0000
611 INJECTION SITE PRURITUS 1 0.0000
612 MEMORY IMPAIRMENT 2 0.0000
613 WEIGHT DECREASED 4 0.0000
614 CONSTIPATION 3 0.0000
615 RESPIRATORY FAILURE 1 0.0000
616 AGITATION 1 0.0000
617 EPISTAXIS 1 0.0000
618 CHRONIC KIDNEY DISEASE 1 0.0000
619 INCORRECT DOSE ADMINISTERED 3 0.0000
620 CARDIAC FAILURE 1 0.0000
621 CARDIAC FAILURE CONGESTIVE 1 0.0000
622 THROMBOSIS 1 0.0000
623 RENAL IMPAIRMENT 1 0.0000
624 BALANCE DISORDER 1 0.0000
625 MALAISE 5 0.0000
626 ADVERSE DRUG REACTION 1 0.0000
627 ADVERSE EVENT 1 0.0000
628 BREAST CANCER 1 0.0000
629 CARDIAC DISORDER 1 0.0000
630 ANXIETY 3 0.0000
631 DYSPHAGIA 1 0.0000
632 DRUG INTOLERANCE 1 0.0000
633 HEART RATE INCREASED 1 0.0000
634 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
635 ABDOMINAL DISTENSION 1 0.0000
636 HAEMORRHAGE 1 0.0000
637 HYPERTENSION 2 0.0000
638 PLATELET COUNT DECREASED 1 0.0000
639 SEPSIS 1 0.0000
640 SEIZURE 1 0.0000
641 DISEASE PROGRESSION 1 0.0000
642 ASTHENIA 3 0.0000
643 RENAL FAILURE 1 0.0000
644 DEATH 6 0.0000
645 DRUG INTERACTION 1 0.0000
646 CONFUSIONAL STATE 1 0.0000
647 FALL 2 0.0000
648 ALOPECIA 1 0.0000
649 SOMNOLENCE 1 0.0000
650 OVERDOSE 1 0.0000